TerSera Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- TerSera Therapeutics's estimated annual revenue is currently $32M per year.
- TerSera Therapeutics's estimated revenue per employee is $203,561
- TerSera Therapeutics has 157 Employees.
- TerSera Therapeutics grew their employee count by 19% last year.
TerSera Therapeutics Competitors & AlternativesAdd Company
|Competitor Name||Revenue||Number of Employees||Employee Growth||Total Funding||Valuation|
What Is TerSera Therapeutics?
TerSera Therapeutics acquires and develops specialty pharmaceutical products with a focus on select therapeutic areas. Our mission is to market products which truly make a difference for patients. Our focus is to bring intelligent solutions to prescribers and patients who need better solutions. We deliver a comprehensive set of programs that go beyond the therapy itself in order to provide improved outcomes for patients.keywords:N/A
Number of Employees
Employee Growth %
TerSera Therapeutics News
... Endo Pharmaceuticals Inc., AbbVie Inc., Contura Ltd., AstraZeneca plc, TerSera Therapeutics LLC, Shire, Informa plc, Merck KGaA.
Boehringer-Ingelheim, TerSera Therapeutics, Iroko Pharmaceuticals, Apotex, Yung Shin Pharmaceutical, Breckenridge Pharmaceutical,...
... Cox-2 Inhibitors Market Set to Witness Explosive Growth by 2029 | Boehringer-Ingelheim, TerSera Therapeutics, Iroko Pharmaceuticals.
Meloxicam Drug Market Latest Trend with Top key players: Boehringer-Ingelheim, TerSera Therapeutics, Iroko Pharmaceuticals, Apotex, Yung ...
Plenty of Opportunities in Meloxicam Drug Market Studied in Detail along with Top Companies as Boehringer-Ingelheim, TerSera Therapeutics, ...
|Company Name||Revenue||Number of Employees||Employee Growth||Total Funding|